{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:10:25Z","timestamp":1793823025914,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-22271-9","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T03:56:04Z","timestamp":1752724564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Awareness and acceptability of long-acting injectable pre-exposure prophylaxis for HIV prevention among female students at tertiary learning institutions: a multi-center, institution-based cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Martin","family":"Kampamba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pumulo","family":"Munawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remmy","family":"Sioma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christabel Mwila","family":"Hikaambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steward","family":"Mudenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukumbi","family":"Mutenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Mukumbuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muchindu","family":"Hampango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzyamba","family":"Malambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunet","family":"Mwalungali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Hamachila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy","family":"Chabalenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Hangoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashebe Innocent","family":"Ngula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Appiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"issue":"1","key":"22271_CR1","first-page":"467","volume":"22","author":"JF Lunkuse","year":"2022","unstructured":"Lunkuse JF, Kamacooko O, Muturi-Kioi V, Chinyenze K, Kuteesa MO, Price MA. Mayanja YJBid: low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala. Uganda. 2022;22(1):467.","journal-title":"Uganda"},{"key":"22271_CR2","doi-asserted-by":"crossref","unstructured":"Tapera T, Odimegwu C, Petlele R, Sello MV, Dzomba A, Aladejebi O, Phiri M. Intersecting epidemics: COVID-19 and HIV in sub-Saharan Africa. A systematic review (2020\u20132022). J Public Health Afr 2023, 14(9).","DOI":"10.4081\/jphia.2023.2658"},{"key":"22271_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijregi.2022.08.009","volume":"5","author":"G Murewanhema","year":"2022","unstructured":"Murewanhema G, Musuka G, Moyo P, Moyo E, Dzinamarira T. HIV and adolescent girls and young women in sub-Saharan Africa: A call for expedited action to reduce new infections. IJID Reg. 2022;5:30\u20132.","journal-title":"IJID Reg"},{"key":"22271_CR4","doi-asserted-by":"crossref","unstructured":"Muyunda B, Musonda P, Mee P, Michelo, CJFiph. Educational attainment as a predictor of HIV testing uptake among women of child-bearing age: analysis of 2014 demographic and health survey in Zambia. 2018, 6:343166.","DOI":"10.3389\/fpubh.2018.00192"},{"key":"22271_CR5","doi-asserted-by":"crossref","unstructured":"Miti A, Thamm S, M\u00fcller P, Cs\u00e1ki A, Fritzsche W, Zuccheri GJB. Bioelectronics: A MiRNA biosensor based on localized surface plasmon resonance enhanced by surface-bound hybridization chain reaction. 2020, 167:112465.","DOI":"10.1016\/j.bios.2020.112465"},{"key":"22271_CR6","doi-asserted-by":"crossref","unstructured":"Rutstein SE, Matoga M, Chen JS, Mathiya E, Ndalama B, Nyirenda N, Bonongwe N, Chithambo S, Chagomerana M, Tegha GJJRP. Integrating enhanced HIV Pre-exposure prophylaxis into a sexually transmitted infection clinic in Lilongwe: protocol for a prospective cohort study. 2022, 11(12):e37395.","DOI":"10.2196\/37395"},{"key":"22271_CR7","doi-asserted-by":"crossref","unstructured":"Dean LT, Predmore Z, Skinner A, Napoleon S, Chan PA, Raifman JJA. Behavior: optimizing uptake of long-acting injectable pre-exposure prophylaxis for HIV prevention for men who have sex with men. 2023, 27(8):2606\u201316.","DOI":"10.1007\/s10461-023-03986-5"},{"key":"22271_CR8","doi-asserted-by":"crossref","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O\u2019reilly KR, Koechlin FM, Rodolph M, Hodges-Mameletzis I, Grant RMJA. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. 2016, 30(12):1973\u201383.","DOI":"10.1097\/QAD.0000000000001145"},{"issue":"22","key":"22271_CR9","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1001\/jama.2019.2591","volume":"321","author":"R Chou","year":"2019","unstructured":"Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, Grusing S, Korthuis PT. Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US preventive services task force. JAMA. 2019;321(22):2214\u201330.","journal-title":"JAMA"},{"issue":"5","key":"22271_CR10","doi-asserted-by":"publisher","first-page":"e048478","DOI":"10.1136\/bmjopen-2020-048478","volume":"12","author":"EO Murchu","year":"2022","unstructured":"Murchu EO, Marshall L, Teljeur C, Harrington P, Hayes C, Moran P, Ryan M. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 2022;12(5):e048478.","journal-title":"BMJ Open"},{"key":"22271_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3463-4","volume":"18","author":"D Sidebottom","year":"2018","unstructured":"Sidebottom D, Ekstr\u00f6m AM, Str\u00f6mdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV\u2013how can we improve uptake and adherence? BMC Infect Dis. 2018;18:1\u201314.","journal-title":"BMC Infect Dis"},{"key":"22271_CR12","doi-asserted-by":"crossref","unstructured":"Moyo PL, Nunu WNJAJMH. Oral pre-exposure prophylaxis uptake and acceptability among men who have sex with men: A scoping review of the literature. 2023, 17(5):15579883231201729.","DOI":"10.1177\/15579883231201729"},{"key":"22271_CR13","doi-asserted-by":"crossref","unstructured":"Grant H, Mukandavire Z, Eakle R, Prudden H, Gomez GB, Rees H, Watts CJAJR, Endoscopy G. When are declines in condom use while using PrEP a concern? Modelling insights from a hillbrow, South Africa case study. 2017, 20(1).","DOI":"10.7448\/IAS.20.1.21744"},{"key":"22271_CR14","doi-asserted-by":"crossref","unstructured":"Ravasi G, Grinsztejn B, Baruch R, Guanira JV, Luque R, C\u00e1ceres CF. Ghidinelli MJJotIAS: towards a fair consideration of PrEP as part of combination HIV prevention in Latin America. 2016, 19:21113.","DOI":"10.7448\/IAS.19.7.21113"},{"key":"22271_CR15","doi-asserted-by":"crossref","unstructured":"Irungu EM. Baeten JMJNm: PrEP rollout in Africa: status and opportunity. 2020, 26(5):655\u201364.","DOI":"10.1038\/s41591-020-0872-x"},{"key":"22271_CR16","doi-asserted-by":"publisher","first-page":"e26107","DOI":"10.1002\/jia2.26107","volume":"26","author":"L Lorenzetti","year":"2023","unstructured":"Lorenzetti L, Dinh N, van der Straten A, Fonner V, Ridgeway K, Rodolph M, Schaefer R, Schmidt HMA, Baggaley R. Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition. J Int AIDS Soc. 2023;26:e26107.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"22271_CR17","first-page":"e25528","volume":"23","author":"AM Minnis","year":"2020","unstructured":"Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, Ngcwayi N, Boeri M, Mansfield C, Bekker LG. Preferences for long-acting pre\u2010exposure prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. Afr J Reprod Gynaecol Endoscopy. 2020;23(6):e25528.","journal-title":"Afr J Reprod Gynaecol Endoscopy"},{"issue":"678","key":"22271_CR18","first-page":"2","volume":"8","author":"P Ngongo","year":"2017","unstructured":"Ngongo P, Mbogua J, Ndegwa J, Githuka G, Bender B, Manguyu F. A survey of stakeholder perceptions towards pre-exposure prophylaxes and prospective HIV microbicides and vaccines in Kenya. J AIDS Clin Res. 2017;8(678):2.","journal-title":"J AIDS Clin Res"},{"issue":"sup2","key":"22271_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/09540121.2020.1742861","volume":"32","author":"R Kidman","year":"2020","unstructured":"Kidman R, Nachman S, Kohler H-P. Interest in HIV pre-exposure prophylaxis (PrEP) among adolescents and their caregivers in Malawi. AIDS Care. 2020;32(sup2):23\u201331.","journal-title":"AIDS Care"},{"key":"22271_CR20","unstructured":"https:\/\/www.prepwatch.org\/wp-content\/uploads\/2024\/01\/CAB-LA_Implementation-Plan_31.01.24-Final.pdf"},{"issue":"7","key":"22271_CR21","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s10461-022-03575-y","volume":"26","author":"A Ogunbajo","year":"2022","unstructured":"Ogunbajo A, Tsai AC, Kanki PJ, Mayer KH. Acceptability of and preferences for long-acting injectable HIV PrEP and other PrEP modalities among sexual minority men in Nigeria, Africa. AIDS Behav. 2022;26(7):2363\u201375.","journal-title":"AIDS Behav"},{"key":"22271_CR22","doi-asserted-by":"crossref","unstructured":"Murray MI, Markowitz M, Frank I, Grant RM, Mayer KH, Hudson KJ, Stancil BS, Ford SL, Patel P. Rinehart ARJHct: satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: patient perspectives from the ECLAIR trial. 2018, 19(4):129\u201338.","DOI":"10.1080\/15284336.2018.1511346"},{"issue":"1","key":"22271_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-10996-2","volume":"21","author":"NL Okeke","year":"2021","unstructured":"Okeke NL, McLaurin T, Gilliam-Phillips R, Wagner DH, Barnwell VJ, Johnson YM, James O, Webb PB, Parker SD, Hill B. Awareness and acceptability of HIV pre-exposure prophylaxis (PrEP) among students at two historically black universities (HBCU): a cross-sectional survey. BMC Public Health. 2021;21(1):1\u20139.","journal-title":"BMC Public Health"},{"issue":"11","key":"22271_CR24","doi-asserted-by":"publisher","first-page":"e005717","DOI":"10.1136\/bmjopen-2014-005717","volume":"4","author":"I Young","year":"2014","unstructured":"Young I, Flowers P, McDaid LM. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ Open. 2014;4(11):e005717.","journal-title":"BMJ Open"},{"issue":"3","key":"22271_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.glohj.2019.09.002","volume":"3","author":"X Chen","year":"2019","unstructured":"Chen X, Yu B, Zhao L. The evaluation of global epidemic of HIV\/AIDS with a novel approach using country-specific counts of HIV infections and three rates controlled for population and geographic area. Global Health J. 2019;3(3):66\u201372.","journal-title":"Global Health J"},{"issue":"1","key":"22271_CR26","first-page":"51","volume":"4","author":"C Simooya","year":"2023","unstructured":"Simooya C, Silumbwe A, Halwindi H, Zulu JM, Nzala SJISC. Exploring communication and implementation challenges of the HIV\/AIDS policy change to test-and-treat-all in selected public health facilities in Lusaka district. Zambia. 2023;4(1):51.","journal-title":"Zambia"},{"key":"22271_CR27","doi-asserted-by":"crossref","unstructured":"Chinsembu KCJE. -bc, medicine a: Ethnobotanical study of plants used in the management of HIV\/AIDS-related diseases in Livingstone, Southern Province, Zambia. 2016, 2016.","DOI":"10.1155\/2016\/4238625"},{"key":"22271_CR28","doi-asserted-by":"crossref","unstructured":"Tolley EE, Zangeneh SZ, Chau G, Eron J, Grinsztejn B, Humphries H, Liu A, Siegel M, Bertha M, Panchia RJA et al. Acceptability of long-acting injectable cabotegravir (CAB LA) in HIV-uninfected individuals: HPTN 077. 2020, 24:2520\u201331.","DOI":"10.1007\/s10461-020-02808-2"},{"key":"22271_CR29","doi-asserted-by":"publisher","first-page":"108058","DOI":"10.1016\/j.jsat.2020.108058","volume":"117","author":"R Shrestha","year":"2020","unstructured":"Shrestha R, DiDomizio EE, Kim RS, Altice FL, Wickersham JA, Copenhaver MM. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs. J Subst Abuse Treat. 2020;117:108058.","journal-title":"J Subst Abuse Treat"},{"key":"22271_CR30","doi-asserted-by":"crossref","unstructured":"Magno L, Leite B, Grangeiro A, Dezanet L, Soares F, Dourado I. Awareness and intention to use event-driven and long-acting injectable pre-exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil. 2023.","DOI":"10.21203\/rs.3.rs-3075825\/v1"},{"issue":"3","key":"22271_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10900-023-01195-8","volume":"48","author":"K Paudel","year":"2023","unstructured":"Paudel K, Gupta S, Gautam K, Wickersham JA, Khati A, Azwa I, Ha T, Shrestha R. High interest in long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention among men who have sex with men (MSM): result from a nationwide survey in Malaysia. J Community Health. 2023;48(3):513\u201321.","journal-title":"J Community Health"},{"issue":"10","key":"22271_CR32","doi-asserted-by":"publisher","first-page":"e0293297","DOI":"10.1371\/journal.pone.0293297","volume":"18","author":"J Fu","year":"2023","unstructured":"Fu J, Dai Z, Wang H, Si M, Chen X, Wu Y, Xiao W, Huang Y, Yu F, Mi G. Willingness to use long-acting injectable PrEP among HIV-negative\/unknown men who have sex with men in Mainland China: A cross-sectional online survey. PLoS ONE. 2023;18(10):e0293297.","journal-title":"PLoS ONE"},{"key":"22271_CR33","doi-asserted-by":"crossref","unstructured":"Okafor CN, Eaton L, Watson R. Willingness to use Long-Acting injectable PrEP among PrEP Na\u00efve black and Hispanic sexual gender minority persons. AIDS Behav 2024:1\u20139.","DOI":"10.1007\/s10461-024-04314-1"},{"key":"22271_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-7276-1","volume":"19","author":"C-Y Cheng","year":"2019","unstructured":"Cheng C-Y, Quaife M, Eakle R, Cabrera Escobar MA, Vickerman P, Terris-Prestholt F. Determinants of heterosexual Men\u2019s demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa. BMC Public Health. 2019;19:1\u20139.","journal-title":"BMC Public Health"},{"issue":"7","key":"22271_CR35","doi-asserted-by":"publisher","first-page":"e0200296","DOI":"10.1371\/journal.pone.0200296","volume":"13","author":"K Meyers","year":"2018","unstructured":"Meyers K, Wu Y, Brill A, Sandfort T, Golub SA. To switch or not to switch: intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience. PLoS ONE. 2018;13(7):e0200296.","journal-title":"PLoS ONE"},{"key":"22271_CR36","doi-asserted-by":"crossref","unstructured":"Chen W, Ding Y, Chen J, Zhao P, Wang Z, Meng X, Jia T, Zheng H, Yang B, Luo ZJBRI. Awareness of and preferences for preexposure prophylaxis (PrEP) among MSM at high risk of HIV infection in Southern China: findings from the T2T Study. 2021, 2021.","DOI":"10.1155\/2021\/6682932"},{"issue":"6","key":"22271_CR37","doi-asserted-by":"publisher","first-page":"e26080","DOI":"10.1002\/jia2.26080","volume":"26","author":"AJ Restar","year":"2023","unstructured":"Restar AJ, Quilantang MI, Wickersham J, Adia A, Guigayoma J, Bermudez AN, Gal\u00e1rraga O, Flores DD, Cu-Uvin S, Nazareno J. Predictors of PrEP awareness, PrEP discussion and interest in long\u2010acting injectable PrEP among filipina transfeminine adults. J Int AIDS Soc. 2023;26(6):e26080.","journal-title":"J Int AIDS Soc"},{"key":"22271_CR38","doi-asserted-by":"crossref","unstructured":"Ajayi AI, Mudefi E, Yusuf MS, Adeniyi OV, Rala N, Ter Goon D. Low awareness and use of pre-exposure prophylaxis among adolescents and young adults in high HIV and sexual violence prevalence settings. Medicine 2019, 98(43).","DOI":"10.1097\/MD.0000000000017716"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22271-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22271-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22271-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:46:02Z","timestamp":1757249162000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22271-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22271"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22271-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval of the study was obtained from the University of Zambia Health Science Research Committee (UNZAHSREC). All methods were carried out following relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"2478"}}